Pre-Open Movers: Meta, Qualcomm Fall; Renewable Stocks Up on Schumer/Manchin Deal

First Solar (FSLR) PT Raised to $135 at Roth Capital

Roth Capital analyst Philip Shen raised the price target on First Solar (NASDAQ: FSLR) to $135.00 (from $85.00) while maintaining a Buy rating.

The analyst comments "FSLR delivered a mixed Q2/lowered its 2022 margin/EPS guidance on project one-timers. While management has a credible... More

JetBlue (JBLU) and Spirit (SAVE) Finally Agree to Merge After Grueling Battle

After four months of back and forth, JetBlue (NASDAQ: JBLU) and Spirit Airlines (NYSE: SAVE) finally announced Thursday that their respective boards have approved a merger agreement. The news comes just one day after Spirit Airlines terminated its merger agreement with Frontier Group (NASDAQ:... More

Teladoc (TDOC) PT Lowered to $40 at JPMorgan, 'We expect the stock to be a show-me story in the near term'

JPMorgan analyst Lisa Gill lowered the price target on Teladoc (NYSE: TDOC) to $40.00 (from $53.00) while maintaining a Neutral rating.

The analyst comments "We highlight a significant market opportunity for telehealth services, which helps to solve two key issues affecting the... More

Stifel Reiterates Buy Rating on Baxter International (BAX)

Stifel analyst Rick Wise reiterated a Buy rating and $75.00 price target on Baxter International (NYSE: BAX)

The analyst comments "Macro challenges have been very much in evidence during initial 2Q22 MedTech reports. In Baxters 2Q, we are seeing the most significant negative... More

Evercore ISI on Baxter International (BAX) Guidance Update: 'we think the magnitude of the cut was a surprise'

Evercore ISI analyst Vijay Kumar reiterated an Outperform rating and $80.00 price target on Baxter International (NYSE: BAX).

The analyst comments "BAX reported organic rev growth of ~3%, which came in ~1% below Guide expectations. Total revs of $3.74 Bn came 3% below ST, and incl Fx impact of -500 bps (we are unsure... More

KeyBanc on Baxter International (BAX), Believes Investors are 'Dissappointed' With Q2 2022 Earnings Report and Guidance Update

KeyBanc analyst Matthew Mishan reiterated an Overweight rating and $87.00 price target on Baxter International (NYSE: BAX).

The analyst comments "We believe investors will view BAXs 2Q22 release and updated 2022 guidance as disappointing. 2Q revenue missed mostly on FX and weaker... More

Sunrun (RUN) Extends Gain, Up 24%

Sunrun (NASDAQ: RUN) Extends Gain, Up 24%